Targeted metagenomic sequencing for all upper respiratory viruses

At the “Innovation Solutions Canada” the Canadian Government asked for solutions towards better detection and prevention of pandemics. Fusion Genomics took up this challenge and developed the ONETest Coronaviruses Plus Assay: a genomic capture assay to accurately and unambiguously diagnose human and animal coronaviruses, all known upper respiratory viruses. The assay when deployed can warn ahead about a potential second wave of COVID-19 (and other zoonotic pathogens) to detect any emerging and re-emerging viruses including SARS-CoV-2 at the human-animal interface.

Critical to the security of Canadian food supply chain, the National Center for Foreign Animal Diseases (NCFAD) will also use the ONETest Coronaviruses Plus Assay in surveillance of various wild and domestic animals for the presence of SARS-CoV-2.

Moreover, Fusion Genomics has now completed all proof-of-concept studies for its ONETest RAPID assay, a faster version of the ONETest Coronaviruses Plus Assay involving two-hour sample to sequencing process

Please contact us if you require more information about using the ONETest Coronaviruses Plus in your organization.